![Systemic lupus erythematosus: a clinical update - Connelly - 2021 - Internal Medicine Journal - Wiley Online Library Systemic lupus erythematosus: a clinical update - Connelly - 2021 - Internal Medicine Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/c68ec4f7-38f3-4b8c-8564-3ce89ac61156/imj15448-fig-0001-m.jpg)
Systemic lupus erythematosus: a clinical update - Connelly - 2021 - Internal Medicine Journal - Wiley Online Library
![Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus - ScienceDirect Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2352646719300122-figs1.jpg)
Utility of serum ferritin and soluble interleukin-2 receptor as markers of disease activity in childhood systemic lupus erythematosus - ScienceDirect
![PDF] Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. | Semantic Scholar PDF] Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/0fe7bbe7e3a7cf3e69d5a3040fb27a1477d84353/5-Table4-1.png)
PDF] Immunoinflammatory markers and disease activity in systemic lupus erythematosus: something old, something new. | Semantic Scholar
![Cureus | Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges Cureus | Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges](https://assets.cureus.com/uploads/figure/file/239498/lightbox_6cc828f0154011ecad9a01b39fdf46ab-Fig-1.png)
Cureus | Neuropsychiatric Systemic Lupus Erythematosus: A 2021 Update on Diagnosis, Management, and Current Challenges
High-Density SNP Screening of the Major Histocompatibility Complex in Systemic Lupus Erythematosus Demonstrates Strong Evidence for Independent Susceptibility Regions | PLOS Genetics
![Diagnostic criteria for systemic lupus erythematosus: has the time come? | Nature Reviews Rheumatology Diagnostic criteria for systemic lupus erythematosus: has the time come? | Nature Reviews Rheumatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fnrrheum.2013.103/MediaObjects/41584_2013_Article_BFnrrheum2013103_Fig1_HTML.jpg)
Diagnostic criteria for systemic lupus erythematosus: has the time come? | Nature Reviews Rheumatology
![Inflammation associated anemia and ferritin as disease markers in systemic lupus erythematosus – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science Inflammation associated anemia and ferritin as disease markers in systemic lupus erythematosus – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science](https://cyberleninka.org/viewer_images/560733/f/1.png)
Inflammation associated anemia and ferritin as disease markers in systemic lupus erythematosus – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science
Hypophosphatemia and Hyponatremia in Systemic Lupus Erythematosus Patients and Its Relation to Clinical Characteristic and Dise
![Frontiers | Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus Frontiers | Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus](https://www.frontiersin.org/files/Articles/688753/fimmu-12-688753-HTML/image_m/fimmu-12-688753-g001.jpg)
Frontiers | Comparison of Surrogate Markers of the Type I Interferon Response and Their Ability to Mirror Disease Activity in Systemic Lupus Erythematosus
![Longitudinal Variation of Proteomic Biomarkers That Correlate with Efficacy Endpoints: Results from a Phase 3 Trial of Anifrolumab in Moderate to Severe Systemic Lupus Erythematosus - ACR Meeting Abstracts Longitudinal Variation of Proteomic Biomarkers That Correlate with Efficacy Endpoints: Results from a Phase 3 Trial of Anifrolumab in Moderate to Severe Systemic Lupus Erythematosus - ACR Meeting Abstracts](https://acrabstracts.org/wp-content/uploads/2022/09/1286281_1.jpg)
Longitudinal Variation of Proteomic Biomarkers That Correlate with Efficacy Endpoints: Results from a Phase 3 Trial of Anifrolumab in Moderate to Severe Systemic Lupus Erythematosus - ACR Meeting Abstracts
![Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity | Nature Communications Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-020-19918-z/MediaObjects/41467_2020_19918_Fig1_HTML.png)
Functionally impaired plasmacytoid dendritic cells and non-haematopoietic sources of type I interferon characterize human autoimmunity | Nature Communications
![PDF] Predictors of outcome and immunological markers in patients with Systemic lupus erythematosus | Semantic Scholar PDF] Predictors of outcome and immunological markers in patients with Systemic lupus erythematosus | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7b9974cb97432d247d83280bdd86acdf0954bf6d/52-Table1.4-1.png)